Recent Signs have Shown That Japan Is Attempting To Improve The … - PharmaLive.com (press release)

Recent Signs have Shown That Japan Is Attempting To Improve The …PharmaLive.com (press release), PA - 20 hours ago… succeeded in negotiating the acquisition of Chugai and more recently, in 2003 Merck & Co. … through the merger between Yamanouchi Pharmaceutical and Fujisawa …

Read full story

Recent Signs have Shown That Japan Is Attempting To Improve The … - Business Wire (press release)

Recent Signs have Shown That Japan Is Attempting To Improve The …Business Wire (press release), CA - 5 hours ago… succeeded in negotiating the acquisition of Chugai and more recently, in 2003 Merck & Co. … through the merger between Yamanouchi Pharmaceutical and Fujisawa …

Read full story

Japanese Stocks May Gain on Elpida's Profit, Higher Oil Prices - Bloomberg

Japanese Stocks May Gain on Elpida's Profit, Higher Oil PricesBloomberg - 1 hour ago… Chugai Pharmaceutical Co. may lead losses by drugmakers after the company said its nine-month profit fell 39 percent from a year ago because of lower sales. … Japanese Stocks May Gain on Elpida's Profit, Higher Oil Prices Bloombergall 5 news articles

Read full story

Japanese Stocks Fall; Dollar Down - Forbes

Japanese Stocks Fall; Dollar DownForbes, NY - Oct 19, 2006… Inc. losing 1.53 percent to 4,500 yen ($37.82) and Chugai Pharmaceutical Co. posting a 1.55 percent drop to 2,535 yen ($21.30). …

Read full story

Japanese stocks fall; dollar down - Houston Chronicle

Japanese stocks fall; dollar downHouston Chronicle, United States - Oct 19, 2006… Inc. losing 1.53 percent to 4,500 yen ($37.82) and Chugai Pharmaceutical Co. posting a 1.55 percent drop to 2,535 yen ($21.30). …

Read full story

Japanese stocks fall; dollar down - BusinessWeek

Japanese stocks fall; dollar downBusinessWeek - 3 hours ago… Inc. losing 1.53 percent to 4,500 yen ($37.82) and Chugai Pharmaceutical Co. posting a 1.55 percent drop to 2,535 yen ($21.30). …

Read full story

Japanese stocks fall, hurt by chipmakers, as investors look at … - Canadian Business

Japanese stocks fall, hurt by chipmakers, as investors look at …Canadian Business, Canada - 3 hours ago… losing 1.53 per cent to 4,500 yen (US$37.82) and Chugai Pharmaceutical Co. posting a 1.55 per cent drop to 2,535 yen (US$21.30). …

Read full story

Tokyo, Hong Kong shares slip as Asian markets end mixed - International Herald Tribune

Tokyo, Hong Kong shares slip as Asian markets end mixedInternational Herald Tribune, France - 1 hour ago… video game console. Other decliners included Advantest Corp., Millea Holdings Inc. and Chugai Pharmaceutical Co. In Hong Kong, shares …

Read full story

Hepatitis :: Roche and InterMune's ITMN-191 HCV protease inhibitor … - SpiritIndia

Hepatitis :: Roche and InterMune's ITMN-191 HCV protease inhibitor …SpiritIndia, India - 10 hours ago… of either co-development or co-commercialization for … years, Roche has led the pharmaceutical industry in … majority ownership interests in Genentech and Chugai. … Roche and InterMune Sign Agreement to Collaborate on the Research … Yahoo! News (press release)all 46 news articles

Read full story

Roche and InterMune Sign Agreement to Collaborate on the Research … - PR Newswire (press release)

Roche and InterMune Sign Agreement to Collaborate on the Research …PR Newswire (press release), NY - Oct 16, 2006… of either co- development or co-commercialization for … years, Roche has led the pharmaceutical industry in … majority ownership interests in Genentech and Chugai. … Roche and InterMune sign agreement to collaborate on the research … PipelineReview.com (press release)all 44 news articles

Read full story

Roche and InterMune sign agreement to collaborate on the research … - PipelineReview.com (press release)

Roche and InterMune sign agreement to collaborate on the research …PipelineReview.com (press release), Spain - 15 hours ago… of either co-development or co-commercialization for … years, Roche has led the pharmaceutical industry in … majority ownership interests in Genentech and Chugai. … Roche and InterMune Sign Agreement to Collaborate on the Research … PharmaLive.com (press release)all 42 news articles

Read full story

Roche and InterMune Sign Agreement to Collaborate on the Research … - PharmaLive.com (press release)

Roche and InterMune Sign Agreement to Collaborate on the Research …PharmaLive.com (press release), PA - 19 minutes ago… of either co- development or co-commercialization for … years, Roche has led the pharmaceutical industry in … majority ownership interests in Genentech and Chugai. … Roche and InterMune sign agreement to collaborate on the research … PipelineReview.com (press release)all 28 news articles

Read full story

Roche and InterMune Sign Agreement to Collaborate on the Research … - Yahoo! News (press release)

Roche and InterMune Sign Agreement to Collaborate on the Research …Yahoo! News (press release) - 4 hours ago… of either co- development or co-commercialization for … years, Roche has led the pharmaceutical industry in … majority ownership interests in Genentech and Chugai. …

Read full story

Plexxikon and Roche Enter Partnership to Develop Targeted Cancer … - International News Service

Plexxikon and Roche Enter Partnership to Develop Targeted Cancer …International News Service, Australia - Oct 4, 2006… As one of the leading pharmaceutical companies in … Plexxikon retains the right to co-promote any … including majority ownership interests in Genentech and Chugai. …

Read full story

Gen-Probe Board OKs Termination Of Shareholder Rights Plan - Easy Bourse (Communiqués de presse)

Gen-Probe Board OKs Termination Of Shareholder Rights PlanEasy Bourse (Communiqués de presse), France - 3 hours ago… Gen-Probe said the termination of its poison pill, which was implemented in 2002 at the time of the company's spinoff from Chugai Pharmaceutical Co. Ltd. …

Read full story